Clinical Trial

Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia

Study acronym: RISTA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
Staphylococcus aureus bacteremia is a serious infection associated with a high mortality rate (with or without associated infective endocarditis (IE)), long hospital stays and multiple complications, due to the terrain in which it occurs and its secondary localization. They may be community-acquired or healthcare-associated infections. Being a carrier of S. aureus is a known risk factor for S. aureus bacteremia. Although several mucosal sites of carriage have been described, screening for carriage is most often carried out at the nasal level, both for reasons of simplicity and because it is the predominant site of carriage of this bacterium. However, S. aureus carriage is a frequent occurrence, affecting around 1/3 of the general population.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-10.
Trial Details
NCT Number NCT06594250
Lead Sponsor Centre Hospitalier Universitaire de Saint Etienne
Conditions Bacteria Infection Mechanism
Enrollment 405 participants
Start Date 2024-09-02
Primary Completion 2025-11 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2024-09-19